Kopran Share Price
Small Cap | Pharmaceuticals and health care | NSE: KOPRAN | BSE: 524280
₹160.75 
2.50 (1.58 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 161.20
High (₹) 163.10
Low (₹) 157.10
Prev. Close (₹) 158.25
Volume 41,577
VWAP (₹) 169.62
ROCE (%) 14.51
Industry P/E 43.95
TTM P/E 16.34
P/B Ratio 1.58
Market Cap (₹) Cr.776.00
Dividend Yield (%)1.87
EPS (₹) 10.57
ROE10.37%
Sales Growth (%) 11.54
Profit Growth (%)87.11
Day Range
163.10163.10
52 Week Range
157.10369.20
Historical Returns
Returns (6M)
-53.99 %
Returns (1Y)
-37.91 %
Returns (3Y)
-44.89 %
Returns (5Y)
689.93 %
Returns (6M)
-53.99 %
Returns (1Y)
-37.91 %
Returns (3Y)
-44.89 %
Returns (5Y)
689.93 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with (87.08%) TTM EPS Growth
- Company with Low Debt
- Book value per share improving over the last 2 years
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Company with 87.08% positive TTM EPS growth
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
Technicals
Technical Rating
BEARISHRSI 39.90
MFI 71.61
ATR 9.94
Commodity Channel Index -95.04
ROC125 -43.23
ROC21 -9.89
Williams %R -77.27
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 174.79 | 180.57 | 184.34 | 171.02 | 165.24 | 161.47 | 155.69 |
| Week Ago | 191.70 | 197.65 | 202.50 | 186.85 | 180.90 | 176.05 | 170.10 |
| Month Ago | 191.56 | 199.33 | 204.01 | 186.88 | 179.11 | 174.43 | 166.66 |
EMA & SMA
160.75
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 181.72
9 Day 177.13
10 Day 174.52
12 Day 175.23
14 Day 176.51
20 Day 178.56
26 Day 182.06
50 Day 195.53
100 Day 228.70
200 Day 251.44
Deals & Announcements
Bulk and Block Deals
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 08 Jan, 2025 | Mridula Somani | Acquisition | ₹ | 17,64,750 | BSE |
| 20 Dec, 2024 | Mridula Somani | Acquisition | ₹ | 17,64,750 | BSE |
| 05 Jun, 2023 | Mridula Somani | Acquisition | ₹10.00 | 2,89,000 | BSE |
| 03 Apr, 2023 | Surendra Somani | Acquisition | ₹107.93 | 28,500 | BSE |
| 03 Apr, 2023 | Surendra Somani | Acquisition | ₹107.08 | 65,500 | BSE |
| 30 Jan, 2023 | Mridula Somani | Acquisition | ₹ | 2,70,500 | BSE |
| 22 Nov, 2022 | HAZARIMALL SOMANI | Acquisition | ₹135.06 | 11,000 | BSE |
| 17 Nov, 2022 | HAZARIMALL SOMANI | Acquisition | ₹149.20 | 10,000 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 16 May, 2024 | Rs.3.0000 per share(30%)Final Dividend | 02 Sept, 2024 | 01 Jan, 1970 |
| 25 May, 2023 | Rs.3.0000 per share(30%)Dividend | 07 Sept, 2023 | 01 Jan, 1970 |
| 27 May, 2022 | Rs.3.0000 per share(30%)Final Dividend | 04 Aug, 2022 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 10 Mar, 2025 | NSE India | The Exchange has sought clarification from Kopran Limited for the quarter ended 31-Dec-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Financial results submitted is not as per format prescribed under Schedule III of the Companies Act, 2013. The response of the Company is awaited. |
| 27 Feb, 2025 | NSE India | Kopran Limited has informed the Exchange about Issue of Duplicate Share Certificate |
| 27 Feb, 2025 | NSE India | KOPRAN LIMITED has informed the Exchange about Issue of duplicate share certificates/Letter of Confirmation |
| 17 Feb, 2025 | BSE India | Transcript and Recording for Earning Q3 FY 2024-25 |
| 17 Feb, 2025 | BSE India | Transcript for Earning Q3 FY 2024-25 |
| 17 Feb, 2025 | NSE India | Kopran Limited has informed the Exchange about Transcript and Link of Recording |
| 13 Feb, 2025 | BSE India | Integrated filing for Q3 2025 financial results |
| 13 Feb, 2025 | NSE India | Kopran Limited has informed the Exchange about Copy of Newspaper Publication |
| 13 Feb, 2025 | NSE India | Integrated filing of Q3 Fy 2025 Financial results |
| 11 Feb, 2025 | BSE India | Investor Presentation for Financial Result Q3 FY 2024-25 |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 05 Feb, 2025 | 11 Feb, 2025 |
| Quarterly Results | -- | 06 Nov, 2024 | 13 Nov, 2024 |
| Quarterly Results | -- | 24 Jul, 2024 | 08 Aug, 2024 |
| Audited Results & Final Dividend | -- | 10 May, 2024 | 16 May, 2024 |
| Quarterly Results | -- | 24 Jan, 2024 | 07 Feb, 2024 |
| Quarterly Results | -- | 27 Oct, 2023 | 07 Nov, 2023 |
| Quarterly Results | -- | 02 Aug, 2023 | 10 Aug, 2023 |
| Audited Results & Dividend | -- | 17 May, 2023 | 25 May, 2023 |
| Quarterly Results | -- | 30 Jan, 2023 | 10 Feb, 2023 |
| Quarterly Results | -- | 02 Nov, 2022 | 11 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Kopran
Kopran is a Public Limited Listed company incorporated on 26/04/1958 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24230MH1958PLC011078 and registration number is 011078. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 337.46 Cr. and Equity Capital is Rs. 48.21 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Parijat Group
Founded
1958
Managing Director
-- --
NSE Symbol
KOPRAN
Kopran Management
| Name | Designation |
|---|---|
| Mr. Susheel G Somani | Chairman |
| Mr. Surendra Somani | Executive Vice Chairman |
| Mr. Adarsh Somani | Director |
| Mr. Varun Somani | Director |
| Dr. Siddhan Subramanian | Independent Director |
| Dr. Sunita Banerji | Independent Director |
| Mrs. Mamta Biyani | Independent Director |
| Mr. Narayan Atal | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Kopran
What is the share price of Kopran?
The share price of Kopran on 13 Mar, 2025 is ₹ 160.75.
What is 52W high and 52W low share price of Kopran?
The highest and lowest 52W share prices of Kopran are ₹ 369.200 and ₹ 157.100
What is the market cap of Kopran?
The market capitalization of Kopran as of 13 Mar, 2025 is ₹ 776.00 Crores
What is the P/E ratio of Kopran?
The current P/E ratio of Kopran as of 13 Mar, 2025 is 43.95
What is the PB ratio of Kopran?
The PB ratio of Kopran as of 13 Mar, 2025 is 1.58
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)